• News
  • Vaccines
    • Clinical Pipeline
  • Immunotherapy
  • PhotoDOX
  • Contact
    • Disclosures

  • News
  • Vaccines
    • Clinical Pipeline
  • Immunotherapy
  • PhotoDOX
  • Contact
    • Disclosures

POP Biotechnologies develops platform technologies addressing critical needs in oncology and infectious disease
Registration has been disabled.

Site Map

  • Clinical Pipeline
  • Contact
  • Disclosures
  • Home
  • Immunotherapy
  • News
  • PhotoDOX
  • Vaccines

Our Mission:

POP Biotechnologies, Inc. (POP BIO) is dedicated to addressing critical medical challenges with advanced nanotechnologies. POP BIO’s key breakthrough, the porphyrin-phospholipid (PoP) platform, facilitates the creation of powerful light-targeted therapeutics and the rapid development of vaccines using liposomes

  • Have any questions?
  • +61 383 766 284
  • noreply@envato.com